VOYA Investment Management
OVID icon

VOYA Investment Management’s Ovid Therapeutics OVID Stock Holding History

VOYA Investment Management’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,819
Closed -$69.6K – 2888
2024
Q1 		$69.6K Sell
22,819
-3,978
-15% -$13.3K ﹤0.01% 2686
2023
Q4 		$86.3K Buy
26,797
+972
+4% +$3.32K ﹤0.01% 2788
2023
Q3 		$99.2K Hold
25,825
– – ﹤0.01% 2738
2023
Q2 		$84.7K Buy
+25,825
New +$87.7K ﹤0.01% 2833
2021
Q2 		– Sell
-23,641
Closed -$95K – 2876
2021
Q1 		$95K Buy
23,641
+3,559
+18% +$11.8K ﹤0.01% 2677
2020
Q4 		$46K Buy
20,082
+5,233
+35% +$24.4K ﹤0.01% 2662
2020
Q3 		$85K Hold
14,849
– – ﹤0.01% 2370
2020
Q2 		$109K Buy
+14,849
New +$69.5K ﹤0.01% 2319

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VOYA Investment Management's OVID Position: Q2 2024 in Review

VOYA Investment Management sold out of Ovid Therapeutics (OVID) in Q2 2024, closing a stake of 22,819 shares — an estimated $69.6K sold.

VOYA Investment Management first reported a position in OVID in Q2 2020 and held it in 8 quarters. The position peaked at $109K in Q2 2020. 74 funds tracked by Wall St. Rank hold OVID as of Q2 2024.

  • VOYA Investment Management reported no remaining Ovid Therapeutics position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 22,819 Ovid Therapeutics shares in Q2 2024, an estimated $69.6K.
  • VOYA Investment Management first reported a position in Ovid Therapeutics in Q2 2020 and held it in 8 quarters.
  • VOYA Investment Management's Ovid Therapeutics position peaked at $109K in Q2 2020.
  • 74 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.